Clinical Trial Update: Study of Risk Factors and Genetic Association With Bortezomib-induced Peripheral Neuropathy in Multiple Myeloma

View source ↗

Summary

This clinical trial update examines risk factors and genetic associations for peripheral neuropathy caused by bortezomib in people with multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Multiple Myeloma | Status: UNKNOWN